https://www.clinicaltrialsarena.com/news/newsamgen-and-allergans-phase-iii-trial-of-abp-215-meets-primary-and-secondary-endpoints-4677896/
Amgen and Allergan have reported positive results from a Phase III trial that evaluated the efficacy and safety of ABP 215 compared with Avastin (bevacizumab)...
phase iii trialamgenallerganabp
https://www.clinicaltrialsarena.com/news/sens401-secondary-endpoint-cochlear/
Sensorion has reported that its hearing loss drug candidate SENS-401 has met secondary endpoints in a Phase IIa proof of concept trial.
phase iiasensmeetssecondaryendpoints